Robert A. Falconer

Bradford, ENG BD71DP, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Exploiting Methyl Triazenes as Attractive Alternatives to Temozolomide and Dacarbazine for Cancer Therapy.

Exploiting Methyl Triazenes as Attractive Alternatives to Temozolomide and Dacarbazine for Cancer Therapy.

Journal: Molecules (Basel, Switzerland)

Published: February 09, 2026

Aminopeptidase N (CD13): Bridging physiology, pathology and therapeutic potential.

Aminopeptidase N (CD13): Bridging physiology, pathology and therapeutic potential.

Journal: Advances in clinical chemistry

Published: October 01, 2025

Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer.

Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: April 29, 2025

Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy.

Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy.

Journal: Nanoscale

Published: March 26, 2025

Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy.

Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy.

Journal: Bioengineering (Basel, Switzerland)

Published: November 19, 2024

Dess-Martin periodinane-mediated oxidation of the primary alcohol of cytidine into a carboxylic acid.

Dess-Martin periodinane-mediated oxidation of the primary alcohol of cytidine into a carboxylic acid.

Journal: Organic & biomolecular chemistry

Published: April 18, 2024

Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer Cells.

Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 11, 2024

The DNA repair kinase ATM regulates CD13 expression and cell migration.

The DNA repair kinase ATM regulates CD13 expression and cell migration.

Journal: Frontiers in cell and developmental biology

Published: December 20, 2023

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues.

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues.

Journal: iScience

Published: June 16, 2023

Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells.

Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells.

Journal: Biochemical pharmacology

Published: March 30, 2022

Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?

Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: September 19, 2021

Progress towards a clinically-successful ATR inhibitor for cancer therapy.

Progress towards a clinically-successful ATR inhibitor for cancer therapy.

Journal: Current research in pharmacology and drug discovery

Published: November 30, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026